Resource Type: Blog

We attended the annual meeting of the American Society of Hematology (ASH) in San Diego. The convention center was abuzz with scientists sharing their research on the clinical utility of…

What do we already know about tumor-immune system interactions, and how can this information be used to help guide us toward the best therapeutic choice? That is exactly the question…

Looking beyond anti-PD1/PDL1 with combination therapy and gene signature testing

Immuno-oncology (IO) focuses on harnessing the tremendous power of the human immune system to detect and destroy cancer cells.